Lymphokine‐activated killer (lak) cells discriminate between epstein‐barr virus (ebv)‐positive burkitt's lymphoma cells
I S Misko(QIMR Berghofer Medical Research Institute), K. Burman(Royal Children's Hospital), Christopher Schmidt(QIMR Berghofer Medical Research Institute), Nicole J. Martin(Royal Brisbane and Women's Hospital), Thomas B. Sculley(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), Denis J. Moss(The University of Queensland)
Cited by 7
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332